Clinical effect of human papillomavirus genotypes in patients with cervical cancer undergoing primary radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 4, 2010, Pages 1111-1120

  Wang, Chun Chieh ^a,b   Lai, Chyong Huey ^a   Huang, Huei Jean ^a   Chao, Angel ^a   Chang, Chee Jen ^b   Chang, Ting Chang ^a   Chou, Hung Hsueh ^a   Hong, Ji Hong ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Cervical cancer; Human papillomavirus; Prognosis; Radiotherapy

Indexed keywords

BELONG TO; CERVICAL CANCERS; CLASSIFICATION AND REGRESSION TREE; CLINICAL EFFECTS; COX REGRESSION; DECISION TREE METHOD; DIFFERENT EFFECTS; GENECHIPS; HAZARD MODELS; HUMAN PAPILLOMAVIRUS; INTERNATIONAL FEDERATION; LYMPH NODE METASTASIS; PROGNOSIS; PROGNOSTIC FACTORS; RADIATION RESPONSE; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOMES;

DECISION TREES; ONCOGENIC VIRUSES; PATHOLOGY;

RADIOTHERAPY;

SQUAMOUS CELL CARCINOMA ANTIGEN; DNA PROBE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME; UTERINE CERVIX CANCER; VIRUS DETECTION; WART VIRUS; ALGORITHM; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CLASSIFICATION; DECISION TREE; DIAGNOSTIC USE; DNA PROBE; GENETICS; MIDDLE AGED; MORTALITY; PAPILLOMA VIRUS; SPECIES DIFFERENCE; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; DECISION TREES; DNA PROBES, HPV; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SPECIES SPECIFICITY; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77958450113     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.09.021     Document Type: Article

References (40)

1. E.M. de Villiers, D. Wagner, and A. Schneider Human papillomavirus infections in women with and without abnormal cervical cytology Lancet 2 1987 703 706
2. J.M. Walboomers, M.V. Jacobs, and M.M. Manos Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19
3. D.M. Parkin, and F. Bray Chapter 2: The burden of HPV-related cancers Vaccine 24 Suppl. 3 2006 S11 S25
4. E.M. de Villiers, C. Fauquet, and T.R. Broker Classification of papillomaviruses Virology 324 2004 17 27
5. J. Doorbar Molecular biology of human papillomavirus infection and cervical cancer Clin Sci (Lond) 110 2006 525 541
6. C.H. Lai, C.J. Chang, and H.J. Huang Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery J Clin Oncol 25 2007 3628 3634
7. B.R. Rose, C.H. Thompson, and J.M. Simpson Human papillomavirus deoxyribonucleic acid as a prognostic indicator in early-stage cervical cancer: A possible role for type 18 Am J Obstet Gynecol 173 1995 1461 1468
8. R.A. Burger, B.J. Monk, and T. Kurosaki Human papillomavirus type 18: Association with poor prognosis in early stage cervical cancer J Natl Cancer Inst 88 1996 1361 1368
9. I. Lombard, A. Vincent-Salomon, and P. Validire Human papillomavirus genotype as a major determinant of the course of cervical cancer J Clin Oncol 16 1998 2613 2619
10. L.W. Huang, S.L. Chao, and J.L. Hwang Human papillomavirus-31-related types predict better survival in cervical carcinoma Cancer 100 2004 327 334
11. H.C. Lai, C.A. Sun, and M.H. Yu Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types Int J Cancer 84 1999 553 557
12. G.B. Kristensen, F. Karlsen, and A. Jenkins Human papilloma virus has no prognostic significance in cervical carcinoma Eur J Cancer 32A 1996 1349 1353
13. P. Viladiu, F.X. Bosch, and X. Castellsague Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer J Clin Oncol 15 1997 610 619
14. R.C. van Muyden, B.W. ter Harmsel, and F.M. Smedts Detection and typing of human papillomavirus in cervical carcinomas in Russian women: a prognostic study Cancer 85 1999 2011 2016
15. H.J. Huang, S.L. Huang, and C.Y. Lin Human papillomavirus genotyping by a polymerase chain reaction-based genechip method in cervical carcinoma treated with neoadjuvant chemotherapy plus radical surgery Int J Gynecol Cancer 14 2004 639 649
16. J.H. Hong, C.S. Tsai, and C.H. Lai Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone Int J Radiat Oncol Biol Phys 63 2005 492 499
17. B. Bachtiary, A. Obermair, and B. Dreier Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer Int J Cancer 102 2002 237 243
18. K. Lindel, P. Burri, and H.U. Studer Human papillomavirus status in advanced cervical cancer: Predictive and prognostic significance for curative radiation treatment Int J Gynecol Cancer 15 2005 278 284
19. R. Munagala, M.G. Dona, and S.N. Rai Significance of multiple HPV infection in cervical cancer patients and its impact on treatment response Int J Oncol 34 2009 263 271
20. H. Pilch, S. Gunzel, and U. Schaffer Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes - Correlation with clinico-pathological parameters and prognostic significance Zentralbl Gynakol 123 2001 91 101
21. G.D. Higgins, M. Davy, and D. Roder Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA Lancet 338 1991 910 913
22. Y. Harima, S. Sawada, and K. Nagata Human papilloma virus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy Int J Radiat Oncol Biol Phys 52 2002 1345 1351
23. M. Graflund, B. Sorbe, and S. Sigurdardottir HPV-DNA, vascular space invasion, and their impact on the clinical outcome in early-stage cervical carcinomas Int J Gynecol Cancer 14 2004 896 902
24. C. Fakhry, and M.L. Gillison Clinical implications of human papillomavirus in head and neck cancers J Clin Oncol 24 2006 2606 2611
25. T. Crook, D. Wrede, and K.H. Vousden p53 Point mutation in HPV negative human cervical carcinoma cell lines Oncogene 6 1991 873 875
26. T.L. DeWeese, J.C. Walsh, and L.E. Dillehay Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation Int J Radiat Oncol Biol Phys 37 1997 145 154
27. N.A. Franken, C. Van Bree, and J. Haveman Differential response to radiation of TP53-inactivated cells by overexpression of dominant-negative mutant TP53 or HPVE6 Radiat Res 161 2004 504 510
28. D. Pyeon, M.A. Newton, and P.F. Lambert Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers Cancer Res 67 2007 4605 4619
29. G. Clifford, and S. Franceschi Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix Int J Cancer 122 2008 1684 1685
30. J.S. Smith, L. Lindsay, and B. Hoots Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update Int J Cancer 121 2007 621 632
31. N. Munoz, F.X. Bosch, and S. de Sanjose Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 2003 518 527 (Pubitemid 36159887)
32. C.H. Lai, H.J. Huang, and S. Hsueh Human papillomavirus genotype in cervical cancer: A population-based study Int J Cancer 120 2007 1999 2006
33. F.X. Bosch, M.M. Manos, and N. Munoz for the A worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. Prevalence of human papillomavirus in cervical cancer J Natl Cancer Inst 87 1995 796 802
34. S.M. Schwartz, J.R. Daling, and K.A. Shera Human papillomavirus and prognosis of invasive cervical cancer: A population-based study J Clin Oncol 19 2001 1906 1915
35. B.A. Werness, A.J. Levine, and P.M. Howley Association of human papillomavirus types 16 and 18 E6 proteins with p53 Science 248 1990 76 79
36. L.L. Villa, and R. Schlegel Differences in transformation activity between HPV-18 and HPV-16 map to the viral LCR-E6-E7 region Virology 181 1991 374 377
37. M.J. Arends, A.H. Wyllie, and C.C. Bird Human papillomavirus type 18 is associated with less apoptosis in fibroblast tumours than human papillomavirus type 16 Br J Cancer 72 1995 646 649
38. L. Hampson, E.S. El Hady, and J.V. Moore The HPV16 E6 and E7 proteins and the radiation resistance of cervical carcinoma FASEB J 15 2001 1445 1447
39. Y. Liu, and J.D. Baleja Structure and function of the papillomavirus E6 protein and its interacting proteins Front Biosci 13 2008 121 134
40. M. Thomas, P. Massimi, and C. Navarro The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins Oncogene 24 2005 6222 6230